Mice Model Market Share | Trends Analysis, 2023-2032

Mice Model Market - By Mice (Inbred, Outbred, Knockout, Hybrid), By Technology (CRISPR, Microinjection, Embryonic Stem Cell Injection, Nuclear Transfer), By Application, By Use, By End-use & Forecast, 2023 – 2032 

Report Content

Chapter 1&nbsp;&nbsp;&nbsp;Methodology &amp; Scope

1.1&nbsp;&nbsp;&nbsp; Industry coverage

1.2&nbsp;&nbsp;&nbsp; Market scope and definitions

1.3&nbsp;&nbsp;&nbsp; Base estimates and working

1.3.1&nbsp;&nbsp;&nbsp; Data collection

1.4&nbsp;&nbsp;&nbsp; Forecast parameters

1.5&nbsp;&nbsp;&nbsp; COVID-19 impact analysis at global level

1.6&nbsp;&nbsp;&nbsp; Data validation

1.7&nbsp;&nbsp;&nbsp; Data sources

1.7.1&nbsp;&nbsp;&nbsp; Primary

1.7.2&nbsp;&nbsp;&nbsp; Secondary

1.7.2.1&nbsp;&nbsp;&nbsp;Paid sources

1.7.2.2&nbsp;&nbsp;&nbsp;Unpaid sources

Chapter 2&nbsp;&nbsp;&nbsp;Executive Summary

2.1&nbsp;&nbsp;&nbsp; Mice model industry 3600 synopsis, 2018 - 2032

2.1.1&nbsp;&nbsp;&nbsp; Business trends

2.1.2&nbsp;&nbsp;&nbsp; Mice Type trends

2.1.3&nbsp;&nbsp;&nbsp; Technology trends

2.1.4&nbsp;&nbsp;&nbsp; Application trends

2.1.5&nbsp;&nbsp;&nbsp; Use trends

2.1.6&nbsp;&nbsp;&nbsp; End-use trends

2.1.7&nbsp;&nbsp;&nbsp; Regional trends

Chapter 3&nbsp;&nbsp;&nbsp;Mice Model Industry Insights

3.1&nbsp;&nbsp;&nbsp; Industry segmentation

3.2&nbsp;&nbsp;&nbsp; Industry landscape, 2018 &ndash; 2032

3.3&nbsp;&nbsp;&nbsp; Industry impact forces

3.3.1&nbsp;&nbsp;&nbsp; Growth drivers

3.3.1.1&nbsp;&nbsp;&nbsp;Rise in the advancements in gene editing tools

3.3.1.2&nbsp;&nbsp;&nbsp;Rising demand for humanized mice models

3.3.1.3&nbsp;&nbsp;&nbsp;Physiological similarities between human and Mice

3.3.1.4&nbsp;&nbsp;&nbsp;Growing consumption of personalized medicine in developing and developed countries

3.3.2&nbsp;&nbsp;&nbsp; Industry pitfalls &amp; challenges

3.3.2.1&nbsp;&nbsp;&nbsp;Ongoing developments of alternative methods to animal testing

3.3.2.2&nbsp;&nbsp;&nbsp;Strict regulations and guidelines

3.3.2.3&nbsp;&nbsp;&nbsp;Growing opposition on mice testing by several organizations

3.4&nbsp;&nbsp;&nbsp; Growth potential analysis

3.4.1&nbsp;&nbsp;&nbsp; By mice type

3.4.2&nbsp;&nbsp;&nbsp; By technology

3.4.3&nbsp;&nbsp;&nbsp; By application

3.4.4&nbsp;&nbsp;&nbsp; By use

3.4.5&nbsp;&nbsp;&nbsp; By end-use

3.5&nbsp;&nbsp;&nbsp; COVID-19 impact analysis

3.6&nbsp;&nbsp;&nbsp; Technological advances in using mice models for studying ovarian cancer

3.7&nbsp;&nbsp;&nbsp; Advantages and disadvantages of in vivo mouse models

3.8&nbsp;&nbsp;&nbsp; Porter&rsquo;s analysis

3.9&nbsp;&nbsp;&nbsp; PESTEL analysis

Chapter 4&nbsp;&nbsp;&nbsp;Competitive Landscape, 2022

4.1&nbsp;&nbsp;&nbsp; Introduction

4.2&nbsp;&nbsp;&nbsp; Company matrix analysis, 2022

4.3&nbsp;&nbsp;&nbsp; Company positioning matrix

4.4&nbsp;&nbsp;&nbsp; Competitive analysis of major market players

4.5&nbsp;&nbsp;&nbsp; Strategic outlook matrix

4.6&nbsp;&nbsp;&nbsp; Strategy dashboard, 2022

Chapter 5&nbsp;&nbsp;&nbsp;Mice Model Market, By Mice Type

5.1&nbsp;&nbsp;&nbsp; Key mice type trends

5.2&nbsp;&nbsp;&nbsp; Inbred

5.2.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, 2018 - 2032 (USD Million)

5.2.2&nbsp;&nbsp;&nbsp; Market estimates and forecast, 2018 - 2032 (000&#39; Units)

5.3&nbsp;&nbsp;&nbsp; Outbred

5.3.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, 2018 - 2032 (USD Million)

5.3.2&nbsp;&nbsp;&nbsp; Market estimates and forecast, 2018 - 2032 (000&#39; Units)

5.4&nbsp;&nbsp;&nbsp; Knockout

5.4.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, 2018 - 2032 (USD Million)

5.4.2&nbsp;&nbsp;&nbsp; Market estimates and forecast, 2018 - 2032 (000&#39; Units)

5.5&nbsp;&nbsp;&nbsp; Hybrid

5.5.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, 2018 - 2032 (USD Million)

5.5.2&nbsp;&nbsp;&nbsp; Market estimates and forecast, 2018 - 2032 (000&#39; Units)

5.6&nbsp;&nbsp;&nbsp; Other mice types

5.6.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, 2018 - 2032 (USD Million)

5.6.2&nbsp;&nbsp;&nbsp; Market estimates and forecast, 2018 - 2032 (000&#39; Units)

Chapter 6&nbsp;&nbsp;&nbsp;Mice Model Market, By Technology

6.1&nbsp;&nbsp;&nbsp; Key technology trends

6.2&nbsp;&nbsp;&nbsp; CRISPR

6.2.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, 2018 - 2032 (USD Million)

6.3&nbsp;&nbsp;&nbsp; Microinjection

6.3.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, 2018 - 2032 (USD Million)

6.4&nbsp;&nbsp;&nbsp; Embryonic stem cell injection

6.4.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, 2018 - 2032 (USD Million)

6.5&nbsp;&nbsp;&nbsp; Nuclear transfer

6.5.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, 2018 - 2032 (USD Million)

6.6&nbsp;&nbsp;&nbsp; Other technologies

6.6.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 7&nbsp;&nbsp;&nbsp;Mice Model Market, By Application

7.1&nbsp;&nbsp;&nbsp; Key application trends

7.2&nbsp;&nbsp;&nbsp; Research &amp; development

7.2.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, 2018 - 2032 (USD Million)

7.2.2&nbsp;&nbsp;&nbsp; Infectious diseases

7.2.2.1&nbsp;&nbsp;&nbsp;Market estimates and forecast, 2018 - 2032 (USD Million)

7.2.3&nbsp;&nbsp;&nbsp; Immunological diseases

7.2.3.1&nbsp;&nbsp;&nbsp;Market estimates and forecast, 2018 - 2032 (USD Million)

7.2.4&nbsp;&nbsp;&nbsp; Cancer

7.2.4.1&nbsp;&nbsp;&nbsp;Market estimates and forecast, 2018 - 2032 (USD Million)

7.2.5&nbsp;&nbsp;&nbsp; Cardiovascular diseases

7.2.5.1&nbsp;&nbsp;&nbsp;Market estimates and forecast, 2018 - 2032 (USD Million)

7.2.6&nbsp;&nbsp;&nbsp; Diabetes

7.2.6.1&nbsp;&nbsp;&nbsp;Market estimates and forecast, 2018 - 2032 (USD Million)

7.2.7&nbsp;&nbsp;&nbsp; Genetic diseases

7.2.7.1&nbsp;&nbsp;&nbsp;Market estimates and forecast, 2018 - 2032 (USD Million)

7.2.8&nbsp;&nbsp;&nbsp; Neurological diseases

7.2.8.1&nbsp;&nbsp;&nbsp;Market estimates and forecast, 2018 - 2032 (USD Million)

7.2.9&nbsp;&nbsp;&nbsp; Other diseases

7.2.9.1&nbsp;&nbsp;&nbsp;Market estimates and forecast, 2018 - 2032 (USD Million)

7.3&nbsp;&nbsp;&nbsp; Production and quality control

7.3.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, 2018 - 2032 (USD Million)

7.4&nbsp;&nbsp;&nbsp; Academics

7.4.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, 2018 - 2032 (USD Million)

7.5&nbsp;&nbsp;&nbsp; Other applications

7.5.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 8&nbsp;&nbsp;&nbsp;Mice Model Market, By Use

8.1&nbsp;&nbsp;&nbsp; Key use trends

8.2&nbsp;&nbsp;&nbsp; Human

8.2.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, 2018 - 2032 (USD Million)

8.3&nbsp;&nbsp;&nbsp; Veterinary

8.3.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 9&nbsp;&nbsp;&nbsp;Mice Model Market, By End-use

9.1&nbsp;&nbsp;&nbsp; Key end-use trends

9.2&nbsp;&nbsp;&nbsp; Companies

9.2.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, 2018 - 2032 (USD Million)

9.2.2&nbsp;&nbsp;&nbsp; Pharmaceutical

9.2.2.1&nbsp;&nbsp;&nbsp;Market estimates and forecast, 2018 - 2032 (USD Million)

9.2.3&nbsp;&nbsp;&nbsp; Biotechnology

9.2.3.1&nbsp;&nbsp;&nbsp;Market estimates and forecast, 2018 - 2032 (USD Million)

9.2.4&nbsp;&nbsp;&nbsp; Cosmetics

9.2.4.1&nbsp;&nbsp;&nbsp;Market estimates and forecast, 2018 - 2032 (USD Million)

9.2.5&nbsp;&nbsp;&nbsp; Other companies

9.2.5.1&nbsp;&nbsp;&nbsp;Market estimates and forecast, 2018 - 2032 (USD Million)

9.3&nbsp;&nbsp;&nbsp; Organisations

9.3.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, 2018 - 2032 (USD Million)

9.3.2&nbsp;&nbsp;&nbsp; Government

9.3.2.1&nbsp;&nbsp;&nbsp;Market estimates and forecast, 2018 - 2032 (USD Million)

9.3.3&nbsp;&nbsp;&nbsp; Non-government

9.3.3.1&nbsp;&nbsp;&nbsp;Market estimates and forecast, 2018 - 2032 (USD Million)

9.4&nbsp;&nbsp;&nbsp; Academic and research institutes

9.4.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, 2018 - 2032 (USD Million)

9.5&nbsp;&nbsp;&nbsp; Contract research organizations (CRO)

9.5.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 10&nbsp;&nbsp;&nbsp;Mice Model Market, By Region

10.1&nbsp;&nbsp;&nbsp; Key regional trends

10.2&nbsp;&nbsp;&nbsp; North America

10.2.1&nbsp;&nbsp;&nbsp; U.S.

10.2.2&nbsp;&nbsp;&nbsp; Canada

10.3&nbsp;&nbsp;&nbsp; Europe

10.3.1&nbsp;&nbsp;&nbsp; Germany

10.3.2&nbsp;&nbsp;&nbsp; UK

10.3.3&nbsp;&nbsp;&nbsp; France

10.3.4&nbsp;&nbsp;&nbsp; Spain

10.3.5&nbsp;&nbsp;&nbsp; Italy

10.3.6&nbsp;&nbsp;&nbsp; Switzerland

10.3.7&nbsp;&nbsp;&nbsp; Netherlands

10.3.8&nbsp;&nbsp;&nbsp; Czech Republic

10.3.9&nbsp;&nbsp;&nbsp; Poland

10.3.10&nbsp;&nbsp;&nbsp; Belgium

10.3.11&nbsp;&nbsp;&nbsp; Finland

10.3.12&nbsp;&nbsp;&nbsp; Hungary

10.3.13&nbsp;&nbsp;&nbsp; Denmark

10.3.14&nbsp;&nbsp;&nbsp; Ireland

10.3.15&nbsp;&nbsp;&nbsp; Sweden

10.3.16&nbsp;&nbsp;&nbsp; Rest of Europe

10.4&nbsp;&nbsp;&nbsp; Asia Pacific

10.4.1&nbsp;&nbsp;&nbsp; China

10.4.2&nbsp;&nbsp;&nbsp; Japan

10.4.3&nbsp;&nbsp;&nbsp; Australia

10.4.4&nbsp;&nbsp;&nbsp; South Korea

10.4.5&nbsp;&nbsp;&nbsp; New Zealand

10.4.6&nbsp;&nbsp;&nbsp; Taiwan

10.4.7&nbsp;&nbsp;&nbsp; Rest of Asia Pacific

10.5&nbsp;&nbsp;&nbsp; Latin America

10.5.1&nbsp;&nbsp;&nbsp; Brazil

10.5.2&nbsp;&nbsp;&nbsp; Mexico

10.5.3&nbsp;&nbsp;&nbsp; Argentina

10.5.4&nbsp;&nbsp;&nbsp; Rest of Latin America

10.6&nbsp;&nbsp;&nbsp; Middle East &amp; Africa

10.6.1&nbsp;&nbsp;&nbsp; South Africa

10.6.2&nbsp;&nbsp;&nbsp; Saudi Arabia

10.6.3&nbsp;&nbsp;&nbsp; UAE

10.6.4&nbsp;&nbsp;&nbsp; Israel

10.6.5&nbsp;&nbsp;&nbsp; Rest of Middle East &amp; Africa

Chapter 11&nbsp;&nbsp;&nbsp;Company Profiles

11.1&nbsp;&nbsp;&nbsp; Charles River Laboratories International, Inc River

11.2&nbsp;&nbsp;&nbsp; Taconic Biosciences, Inc.

11.3&nbsp;&nbsp;&nbsp; Janvier Labs

11.4&nbsp;&nbsp;&nbsp; genOway

11.5&nbsp;&nbsp;&nbsp; Hera Biolabs

11.6&nbsp;&nbsp;&nbsp; TransViragen Inc.

11.7&nbsp;&nbsp;&nbsp; The JACKSON LABORATORY

11.8&nbsp;&nbsp;&nbsp; Inotiv

11.9&nbsp;&nbsp;&nbsp; Allentown LLC

11.10&nbsp;&nbsp;&nbsp; Harbour Biomed

11.11&nbsp;&nbsp;&nbsp; PolyGene 
&nbsp;

Mice Model Market

Get a free sample of this report

Industries

Information

Link

Global Headquarters